Furthermore, FXR is proposed to be involved in the development and progression of multiple types of carcinoma, including breast carcinoma, clear cell renal carcinoma, colorectal carcinoma, and hepatocellular carcinoma. Here, NR1H4 is linked to breast carcinoma.